logo
logo
Sign in

Telemedicine is fastest growing segment fueling the growth of Global Panic Attack Treatment Market

avatar
naufan003
Telemedicine is fastest growing segment fueling the growth of Global Panic Attack Treatment Market

The global Panic Attack Treatment Market is estimated to be valued at US$ 2.04 Bn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Panic attacks refer to sudden episodes of intense fear or discomfort that develop abruptly and reach a peak within minutes. Common symptoms include chest pain, shortness of breath, dizziness, and sweating. Treatment for panic attacks usually involves counseling or therapy to help people change anxious thought patterns. Medications and lifestyle modifications also help reduce symptoms.

Market key trends:

One of the major trends fueling the growth of the global panic attack treatment market is emergence of telemedicine. Telemedicine enables remote diagnosis and treatment of panic attacks and associated anxiety disorders using telecommunication technology. It allows patients to access healthcare services from the comfort of their homes through smartphones, tablets or computers. Various apps and telehealth platforms assist healthcare providers in monitoring patients, offering counseling through video conferences and prescribing medication refills. This makes treatment more accessible and affordable for patients in remote locations.

Segment Analysis

The global panic attack treatment market can be segmented based on disorder type, therapeutic class, distribution channel, and region. By disorder type, the market can be classified into agoraphobia, social anxiety disorder, specific phobia, general anxiety disorder, and panic disorder. The panic disorder segment dominated other segments in 2023 due to rise in the prevalence of panic disorder worldwide.

Key Takeaways

The Global Panic Attack Treatment Market Size is expected to witness high growth, exhibiting CAGR of 7.3% over the forecast period, due to increasing prevalence of mental health disorders and rising awareness about the availability of effective treatment options.

Regional analysis: Regionally, North America dominated the global market in 2023 followed by Europe. This is attributed to rising adoption of panic attack treatment medications in countries like the U.S. and Canada. However, Asia Pacific is expected to witness fastest growth over the forecast period owing to improving healthcare infrastructure and growing healthcare expenditure in emerging economies like China and India.

Key players: Key players operating in the panic attack treatment market are GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., H. Lundbeck A/S.


Get more insights on this topic:

https://www.dailyprbulletin.com/panic-attack-treatment-market-size-forecast/

collect
0
avatar
naufan003
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more